| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/22/2011 | US20110230446 Cathepsin cysteine protease inhibitors |
| 09/22/2011 | US20110230445 Substituted Heteroaryls |
| 09/22/2011 | US20110230444 Pharmaceutical combination comprising a hsp 90 inhibitor and a mtor inhibitor |
| 09/22/2011 | US20110230443 IMIDAZO[1,2-a] PYRIDINYL BISPHOSPHONATES |
| 09/22/2011 | US20110230442 Na channels, disease, and related assays and compositions |
| 09/22/2011 | US20110230441 Stable bortezomib formulations |
| 09/22/2011 | US20110230440 Inhibitors of fatty acid amide hydrolase |
| 09/22/2011 | US20110230439 Methods of reducing absorption of trans fatty acids using water-soluble cellulose derivatives |
| 09/22/2011 | US20110230438 Viscoelastic gel for dermatological use |
| 09/22/2011 | US20110230436 Uracyl Cyclopropyl Nucleotides |
| 09/22/2011 | US20110230435 Methods and Compositions for Treating Obesity and Related Disorders |
| 09/22/2011 | US20110230434 Use of s-adenosylmethionine, vitamin e, and vitamin c for the treatment of oxidative liver injury or insulin resistance |
| 09/22/2011 | US20110230433 Compositions and methods for treatment of cancer |
| 09/22/2011 | US20110230432 Compositions and kits for treating influenza |
| 09/22/2011 | US20110230431 Fosfomycin/tobramycin combinations for the treatment and prevention of ophthalmic, otological and dermatological infections |
| 09/22/2011 | US20110230430 Saponin extract from saponaria spp. and uses thereof |
| 09/22/2011 | US20110230429 Avermectin b1 and avermectin b1 monosaccharide derivatives having an alkoxymethyl substituent in the 4"-or 4'-position |
| 09/22/2011 | US20110230428 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 09/22/2011 | US20110230419 Iap binding compounds |
| 09/22/2011 | US20110230414 Pyrrolopyrazine Kinase Inhibitors |
| 09/22/2011 | US20110230407 Hepatocyte growth factor pathway activators in demyelinating diseases and central nervous system trauma |
| 09/22/2011 | US20110230403 Glycoside derivatives and uses thereof |
| 09/22/2011 | US20110230400 Nutritional composition for wound healing |
| 09/22/2011 | US20110230392 Novel narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, and narc 25 molecules and uses therefor |
| 09/22/2011 | US20110229890 Egfr mutations |
| 09/22/2011 | US20110229590 Pharmaceutical composition comprising ginger extract or shogaol |
| 09/22/2011 | US20110229585 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 09/22/2011 | US20110229581 Releasable cationic lipids for nucleic acids delivery systems |
| 09/22/2011 | US20110229580 Compositions and methods for nano-in-micro particles |
| 09/22/2011 | US20110229578 Modafinil oral lyophilizate |
| 09/22/2011 | US20110229576 Hollow silica nanospheres and methods of making same |
| 09/22/2011 | US20110229572 Delivery of drug combinations |
| 09/22/2011 | US20110229571 Pharmaceutical Compositions Comprising a Selective I1 Imidazoline Receptor Agonist and an Angiotensin II Receptor Blocker |
| 09/22/2011 | US20110229570 Orally rapidly disintegrating tablet and process for producing same |
| 09/22/2011 | US20110229569 Compositions exhibiting delayed transit through the gastrointestinal tract |
| 09/22/2011 | US20110229568 Michael systems as transglutaminase inhibitors |
| 09/22/2011 | US20110229567 Solid pharmaceutical composition |
| 09/22/2011 | US20110229566 Single Unit Oral Dose Pharmaceutical Composition Comprising Levodopa, Carbidopa And Entacapone Or Salts Thereof |
| 09/22/2011 | US20110229565 Drug Delivery Composition Comprising a Self-Assembled Gelator |
| 09/22/2011 | US20110229564 Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof |
| 09/22/2011 | US20110229563 Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity |
| 09/22/2011 | US20110229562 Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol |
| 09/22/2011 | US20110229561 Extended Release Pharmaceutical Composition Of Entacapone Or Salts Thereof |
| 09/22/2011 | US20110229560 Nlrc5 as a target for immune therapy |
| 09/22/2011 | US20110229559 Drug Release From Nanoparticle-Coated Capsules |
| 09/22/2011 | US20110229558 Agent for treating myelofibrosis |
| 09/22/2011 | US20110229557 Methods for treating eye disorders |
| 09/22/2011 | US20110229555 Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders |
| 09/22/2011 | US20110229554 INTRAVENOUS FORMULATIONS OF COENZYME Q10 (CoQ10) AND METHODS OF USE THEREOF |
| 09/22/2011 | US20110229552 NOVEL mRNA SPLICE VARIANT OF THE DOUBLECORTIN-LIKE KINASE GENE AND ITS USE IN DIAGNOSIS AND THERAPY OF CANCERS OF NEUROECTODERMAL ORIGIN |
| 09/22/2011 | US20110229551 Drug delivery compositions and methods using nanofiber webs |
| 09/22/2011 | US20110229550 Acid-Degradable and Bioerodible Modified Polyhydroxylated Materials |
| 09/22/2011 | US20110229548 Implantable Medical Device With Poly(Vinylidene Fluoride-Co-Hexafluoropropylene)/Zotarolimus Drug Layer |
| 09/22/2011 | US20110229546 Treatment of dissection, aneurysm, and atherosclerosis using granzyme b inhibitors |
| 09/22/2011 | US20110229544 Methods for Inhibiting Gram-Postive Bacteria Using Non-Phospholipid Lipid Vesicules |
| 09/22/2011 | US20110229535 Composition having a sirtuin activator |
| 09/22/2011 | US20110229534 Non-Irritating Oral Care Formulations |
| 09/22/2011 | US20110229533 Extended release dosage form |
| 09/22/2011 | US20110229532 Process for nanoemulsification of curcumin and derivatives of curcumin |
| 09/22/2011 | US20110229531 Anti-protozoa compounds |
| 09/22/2011 | US20110229530 Pharmaceutical dosage forms for time-specific drug delivery |
| 09/22/2011 | US20110229528 Pegylated polyplexes for polynucleotide delivery |
| 09/22/2011 | US20110229526 Formulations of nonopioid and confined opioid analgesics |
| 09/22/2011 | US20110229524 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of Gastric Cancer and other cancers |
| 09/22/2011 | US20110229521 Nutritional support of the immune system during anti-cancer treatment |
| 09/22/2011 | US20110229515 Identification of genes |
| 09/22/2011 | US20110229504 Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| 09/22/2011 | US20110229503 Vaccination against malignant melanoma using bcg and/or vaccinia |
| 09/22/2011 | US20110229501 Organic compounds |
| 09/22/2011 | US20110229500 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 09/22/2011 | US20110229495 Methods for predicting development of auto-immune diseases and treatment of same |
| 09/22/2011 | US20110229494 Teneurin and cancer |
| 09/22/2011 | US20110229493 Neuregulin antagonists and use thereof in treating cancer |
| 09/22/2011 | US20110229492 Compositions and methods for diagnosing, treating, and preventing prostate conditions |
| 09/22/2011 | US20110229491 Minichromosome maintenance complex interacting protein involved in cancer |
| 09/22/2011 | US20110229485 Inhibition of the nt-3:trkc bound and its application to the treatment of cancer such as neuroblastoma |
| 09/22/2011 | US20110229484 Host Cell Kinases as Targets for Antiviral Therapies Against HCV Infection |
| 09/22/2011 | US20110229478 Erbb3 based methods and compositions for treating neoplasms |
| 09/22/2011 | US20110229474 Monitoring and inhibiting human immunodeficiency virus infection by modulating hmgb1 dependent triggering of hiv-1 replication and persistence |
| 09/22/2011 | US20110229468 Targeting pax2 for the treatment of breast cancer |
| 09/22/2011 | US20110229467 Targeting pax2 for the treatment of breast cancer |
| 09/22/2011 | US20110229465 Composition for treating disease |
| 09/22/2011 | US20110229464 Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues |
| 09/22/2011 | US20110229457 Injectable drug delivery system |
| 09/22/2011 | US20110229456 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 09/22/2011 | US20110229449 Prophylaxis and treatment of macular degeneration and retinopathy using a prdx protein |
| 09/22/2011 | US20110229447 Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment |
| 09/22/2011 | US20110229446 Method and composition to relieve sexual discomfort and improve vaginal health |
| 09/22/2011 | US20110229438 Method of inhibiting hepatitus c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds |
| 09/22/2011 | US20110229437 Method of Treating Asthma with Antiviral Agents |
| 09/22/2011 | US20110229435 Expression and purification of hip/pap and uses therefor |
| 09/22/2011 | US20110229432 Thermosensitive composition preventing tissue adhesion and preparation method thereof |
| 09/22/2011 | US20110229423 Pacap signaling pathway modulators for treating inflammatory skin diseases having a neurogenic component, notably rosacea, and compositions comprised thereof |
| 09/22/2011 | US20110229418 Compositions and Methods of Treating and Preventing Lung Cancer |
| 09/22/2011 | US20110229409 Linkable lewis x analogs |
| 09/22/2011 | US20110229408 Sodium-iodide symporter gene repressor binding site |
| 09/22/2011 | DE102011013142A1 Composition, useful for the care and treatment of the skin, preferably for the relief of psoriasis and atopic eczema, and increasing the natural moisture of the skin and promoting skin regeneration, comprises leucaderm emulsion |
| 09/22/2011 | DE102010012384A1 Hautfreundliche Wirkstoffkombination gegen Akne Skin-friendly drug combination against acne |
| 09/22/2011 | DE102010012282A1 Pharmazeutische Zusammensetzung enthaltend Cyclodextrin-Copolymer A pharmaceutical composition comprising cyclodextrin copolymer |
| 09/22/2011 | DE102010012281A1 Pharmazeutische Zusammensetzungen enthaltend substituiertes 6-Deoxy-6-sulfanylcyclodextrin To pharmaceutical compositions containing substituted 6-deoxy-6-sulfanylcyclodextrin |